Convertible debt Convertible Debt Convertible Debt, Total 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Document Transition Report Document Transition Report Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Weighted Average Remaining Contractual Term (In Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Money Market Funds [Member] Money Market Fund [Member] Research development and regulatory milestone. Research Development And Regulatory Milestone [Member] Research Development And Regulatory Milestone Payments of Stock Issuance Costs Payments of stock issuance costs Share based compensation arrangement by share based payment award vesting number of quarterly installment succeeding period. Share Based Compensation Arrangement By Share Based Payment Award Vesting Number Of Quarterly Installment Succeeding Period Number of quarterly installments for vesting succeeding period Adimab Platform Transfer Agreement [Member] Adimab Platform Transfer Agreement [Member] Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage Percentage of eligible participants of non-elective contributions Amount paid for services Amount Paid For Services Amount paid for services Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Securities, available for offer and sale Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale, Total Other non-current liability Other Liabilities, Noncurrent Increase (Decrease) in Prepaid Expense and Other Assets, Total Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Fair Value, Inputs, Level 1 [Member] Level 1 [Member] License Agreements. License Agreements [Abstract] Lessee, Operating Lease, Liability, to be Paid, Year Four 2026 Php Warrants Outstanding [Member] PHP Warrants Outstanding [Member] PHP Warrants Outstanding [Member] Fair Value Disclosures [Text Block] Fair Value Measurements Convertible preferred stock, shares authorized Temporary Equity, Shares Authorized Other current liabilities Increase (Decrease) in Other Current Liabilities Milestone payment. Milestone Payment Milestone payment Prepaid Expense and Other Assets, Current [Abstract] Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Total unrecognized stock-based compensation cost Equity incentive plan. Equity Incentive Plan [Member] 2020 Equity Incentive Plan Title of Individual [Domain] Two Thousand And Twenty Two Employee Stock Purchase Plan [Member] Two Thousand And Twenty Two Employee Stock Purchase Plan [Member] Two Thousand And Twenty Two Employee Stock Purchase Plan Subsequent Events [Text Block] Subsequent Events Convertible preferred stock, shares issued Temporary Equity, Shares Issued Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis Operating Lease, Liability, Noncurrent Operating lease liability, non-current Stock Repurchased During Period, Shares Shares repurchased Issuance of Series A convertible preferred stock in exchange for license and common stock, shares Assets, Fair Value Disclosure [Abstract] Assets: Related Party Transactions [Abstract] Assets, Current Total current assets Liabilities and Equity Total liabilities, preferred stock and stockholders' equity Entity Address, State or Province Entity Address, State or Province Impact of Adoption [Member] Impact of Adoption [Member] Impact of Adoption [Member] Acquired in-process research and development Acquired in-process research and development. Acquired In Process Research And Development Outstanding at September 30, 2023 Outstanding at December 31, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Fair value of common stock Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss 2023 (excluding the nine months ended September 30, 2023) Purchase Obligation, to be Paid, Remainder of Fiscal Year Trading Symbol Trading Symbol Common Stock, Shares, Issued, Total Common Stock, Shares, Issued Common stock, shares issued (in shares) Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Prepaid expenses and other current assets Exercise of stock options Exercise of stock options Exercise of stock options Numerator Net Income (Loss) Attributable to Parent [Abstract] Cash and Cash Equivalents [Member] Cash Equivalents [Member] Shares, Outstanding Balances, shares Balances, shares 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Accumulated Other Comprehensive Income [Member] AOCI Attributable to Parent [Member] Entity Address, City or Town Entity Address, City or Town Related Party Transaction [Line Items] Related Party Transaction [Line Items] Common stock, conversion basis Common Stock, Conversion Basis Exercisable common stock Class of Warrant or Right, Outstanding Lessee, Operating Lease, Renewal Term Lease term Prepaid Compensation And Related Expenses Prepaid compensation and related expenses Prepaid compensation and other Subsequent Event [Member] Subsequent Event Subsequent Event Type [Axis] Subsequent Event Type Chief Executive Officer [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Accrued Upfront Fee. Accrued Upfront Fee Accrued Upfront Fee Amortization Amortized Cost Amortization Cost Series B Preferred Stock [Member] Series B Preferred Stock [Member] Liabilities, Current [Abstract] Current liabilities: Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer Assets, Current [Abstract] Current assets: Preferred Stock, Par or Stated Value Per Share Preferred stock par value (in dollars per share) Statement of Stockholders' Equity [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted-Average Exercise Price,Vested and expected to vest at June 30, 2023 Operating Lease, Liability, Current Operating lease liability, current Marketable Securities, Policy [Policy Text Block] Marketable Securities Denominator Earnings Per Share, Basic, Other Disclosure [Abstract] Property, Plant and Equipment, Net, Total Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net Property and equipment, net Series A Preferred Stock [Member] Series A Preferred Stock [Member] Class of Stock [Domain] Class of Stock Two Thousand And Twenty One Employee Stock Purchase Plan Member Two Thousand And Twenty One Employee Stock Purchase Plan [Member] Two Thousand And Twenty One Employee Stock Purchase Plan Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate Intrinsic Value, Vested and Expected to vest at June 30, 2023 Unrealized Gain on Marketable Securities Unrealized Gain on Marketable Securities Unrealized Gains Unrealized Gains Statement of Comprehensive Income [Abstract] Scenario [Domain] Treasury Stock, Common, Shares Treasury Stock, Common, Shares Entity Central Index Key Entity Central Index Key WuXi Cell Line License Agreement. Wu Xi Cell Line License Agreement [Member] Cell Line License Agreement [Member] Plan Name [Domain] Plan Name Assets, Fair Value Disclosure, Total Assets, Fair Value Disclosure Assets, fair value disclosure Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding Preferred stock, shares outstanding (in shares) Liabilities, Current Total current liabilities Entity Tax Identification Number Entity Tax Identification Number Due from Related Party Due From Related Party Due From Related Party Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Optimization Completion Fee Optimization Completion Fee Optimization Completion Fee. Optimization Completion Fee Adimab [Member] Adimab [Member] Adimab [Member] Common stock, $0.0001 par value; 1,000,000,000 shares authorized,109,773,173 shares issued and 108,780,525 shares outstanding at June 30, 2022; 1,000,000,000 shares authorized, 111,251,660 shares issued and 110,782,909 shares outstanding at December 31, 2021 Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value Carrying Value Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock under the employee stock purchase plan Award Type [Axis] Award Type Restricted Stock [Member] Restricted Stock [Member] Other Commitments [Abstract] Plan Name [Axis] Plan Name Assets Total assets Operating Lease, Right-of-Use Asset Operating lease right-of-use asset Series C Convertible Preferred Stock [Member] Series C convertible preferred stock. Series C Convertible Preferred Stock [Member] Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Liability for unvested shares November 15, 2028 [Member] Fifteen November Two Thousand Twenty Eight Member Fifteen November Two Thousand Twenty Eight Member Acquired in-process research and development expense. Acquired In Process Research And Development Expense Acquired IPR&D expense Retirement Plan Name [Domain] Retirement Plan Name Entity Registrant Name Entity Registrant Name Entity Address, Address Line Three Entity Address, Address Line Three Related Party, Type [Domain] Related Party Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated Deficit Organization, Consolidation and Presentation of Financial Statements line items. Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items] Retained Earnings [Member] Accumulated Deficit [Member] Class of Stock [Axis] Class of Stock Ending Balance at September 30, 2023 Beginning Balance at December 31, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Cash paid for amounts included in the measurement of lease liabilities: Payment for Pension and Other Postretirement Benefits [Abstract] Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock under the employee stock purchase plan, shares Minimum Minimum [Member] Minimum [Member] Proceeds from Stock Options Exercised Proceeds from exercises of stock options Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Operating cash flows related to operating leases Operating Lease, Liability Present value of operating lease liability Present value of operating lease liability Equity Component [Domain] Equity Component Defined Contribution Plan, Cost Defined contribution amount Share-Based Payment Arrangement, Option [Member] Employee Stock Option [Member] Conversion of Stock, Shares Converted Convertible preferred stock outstanding converted into common stock Two Thousand And Twenty Employee Stock Purchase Plan Two Thousand And Twenty Employee Stock Purchase Plan Member Two Thousand And Twenty Employee Stock Purchase Plan Member ATM Facility [Member] ATM Facility [Member] Convertible preferred stock shares reserved for future issuance Convertible Preferred Stock, Shares Reserved for Future Issuance Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Measurement Frequency [Axis] Measurement Frequency A And R Commercial Manufacturing Agreement [Member] A And R Commercial Manufacturing Agreement [Member] A&R Commercial Manufacturing Agreement Marketable Securities [Abstract] Entity Current Reporting Status Entity Current Reporting Status Common Stock, Shares Authorized Common stock, shares authorized (in shares) Research and development Research and Development Expense, Total Research and Development Expense Research and development expense Proceeds from issuance of convertible preferred stock, net of issuance costs paid Proceeds from Issuance of Convertible Preferred Stock Assets Assets [Abstract] Proceeds from Issuance of Common Stock Proceeds from issuance of common stock under the employee stock purchase plan Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Shares available for future issuance Interest Receivable, Current Interest receivable Convertible Preferred Stock Member Convertible Preferred Stock [Member] Common stock, $0.0001 par value; 1,000,000,000 shares authorized, 109,846,329 shares issued and outstanding at September 30, 2023; 109,044,046 shares issued and outstanding at December 31, 2022 Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Share based compensation arrangement by share based payment award options exercise price percentage of fair value of common stock. Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price Percentage Of Fair Value Of Common Stock Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than) Accrued Liabilities, Current Accrued expenses Accrued Liabilities, Current, Total Current Fiscal Year End Date Current Fiscal Year End Date Share-based Payment Arrangement, Noncash Expense, Total Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Operating Income (Loss) Loss from operations Loss from operations Research and developmet expenses Research and Developmet Expenses Research and Developmet Expenses Entity Ex Transition Period Entity Ex Transition Period Income Tax Expense (Benefit), Total Income Tax Expense (Benefit) Income tax expense (benefit) Weighted-average remaining contractual term (Years) Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Research and Development Expense [Member] Research and Development [Member] Research and Development Expense [Member] Contractual Obligation, Fiscal Year Maturity [Table Text Block] Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations Lessee, Leases [Policy Text Block] Leases Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Share-Based Payment Arrangement, Expense Stock based compensation expense Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Percentage of options vesting Increase (Decrease) in Operating Lease Liability Operating lease liabilities Payments to Acquire Royalty. Payments To Acquire Royalty Payments to acquire royalty Deferred offering and issuance cost included in accrued expenses Deferred offering and issuance cost included in accrued expenses Treasury Stock, Shares, Retired Retirement of treasury shares, shares Aggregate Intrinsic Value, Outstanding at December 31, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding at June 30, 2023 Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Common shares repurchased Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Sale of Stock, Price Per Share Sale of stock, price per share Costs and Expenses, Related Party Related party expenses Quarterly Fee. Quarterly Fee Quarterly fee Operating Expenses [Abstract] Operating expenses: Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Unrealized gain on available-for-sale securities, net of tax License fees received Proceeds from License Fees Received Subsequent Events [Abstract] Commitments and Contingencies Disclosure [Abstract] Other Assets, Noncurrent, Total Other Assets, Noncurrent Other non-current assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Granted Equity [Text Block] Common Stock Federal Agency Securities [Member] Agency Securities [Member] Depreciation, Total Depreciation Depreciation expense Series A Convertible Preferred Stock [Member] Series A convertible preferred stock. Series A Convertible Preferred Stock [Member] Undesignated preferred stock capital shares reserved for future issuance. UndesignatedPreferredStockCapitalSharesReservedForFutureIssuance Undesignated preferred stock capital shares reserved for future issuance Equity, Attributable to Parent [Abstract] Stockholders' equity (deficit): Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Lease, Cost [Table Text Block] Schedule of Components of Operating Lease Expense Partners' Capital Account, Public Sale of Units Net of Offering Costs Security for sale offering PHP Member PHP Member Earnings Per Share [Abstract] Operating lease right-of-use asset recognized Operating lease right-of-use asset recognized Borrowing rate Subordinated Borrowing, Interest Rate Accounting Policies [Abstract] Second Product. Second Product [Member] Second Product [Member] In Process Research and Development [Member] In Process Research and Development [Member] Scenario [Axis] Purchase price of shares Sale of Stock, Consideration Received on Transaction Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share based compensation arrangement by share based payment award vesting number of quarterly installment. Share Based Compensation Arrangement By Share Based Payment Award Vesting Number Of Quarterly Installment Number of quarterly installments for vesting Supplemental Cash flow information operating lease. Supplemental Cash Flow Information Operating Lease [Table Text Block] Schedule of Supplemental Information Related to Operating Leases Long-Term Purchase Commitment [Table] Share based compensation arrangement by share based payment award equity instruments other than options repurchased in period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Repurchased In Period Repurchased Repurchased Net loss per share attributable to common stockholders, basic and diluted Earnings Per Share, Basic Earnings Per Share, Basic, Total Schedule of Cash and Cash Equivalents [Table] Commitments and Contingencies Commitments and contingencies (Note 9) Total cost incurred Related Party, Type [Axis] Related Party Early-exercise liability. Early Exercise Liability Early-exercise liability Operating Lease, Cost Operating lease cost Retirement Benefits [Abstract] Vested and expected to vest at September 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Statistical Measurement [Domain] Statistical Measurement Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Fees to be paid in cash Cash Fees Cash fees All Award Types Award Type Royalty, Percentage of Sublicense Consideration. Royalty Percentage Of Sublicense Consideration Royalty percentage of sublicense consideration Document Period End Date Document Period End Date Statistical Measurement [Axis] Statistical Measurement Potential milestone payment. Potential Milestone Payment Potential milestone payment Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies The entire disclosure for prepaid expenses and other current assets. Prepaid Expenses Other Current Assets [Text Block] Prepaid Expenses and Other Current Assets Operating Lease, Payments Operating cash flows related to operating leases Net loss per share attributable to common stockholders, basic and diluted Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Product and Service [Domain] Product and Service Lease cost Lease, Cost [Abstract] Cash paid for amounts included in the measurement of lease liabilities: Net issuance cost of convertible preferred stock. Net Issuance Cost Of Convertible Preferred Stock Convertible preferred stock, net of issuance costs Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Options exercisable at September 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Increase (Decrease) in Other Noncurrent Liabilities Other non-current liabilities Related Party Transaction [Domain] Related Party Transaction Fair Value, Recurring [Member] Fair Value, Recurring [Member] Fair value transfers between levels transfers amount. Fair Value Transfers Between Levels Transfers Amount Transfers between level 3 Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock Additional paid-in capital Defined Contribution Plan Disclosure [Line Items] Defined Contribution Plan Disclosure [Line Items] U.S. Treasury Securities [Member] US Treasury Securities [Member] Preferred stock original issue and conversion price per share. Preferred Stock Original Issue And Conversion Price Per Share Preferred stock original issue and conversion price, per share Payments for Repurchase of Common Stock Payments for repurchases of unvested restricted common stock Adimab Collaboration Agreement. Adimab Collaboration Agreement [Member] Adimab Collaboration Agreement [Member] Population Health Partners, L.P Other Commitment Disclosure [Text Block] Other Commitment Disclosure [Text Block] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercised Exercise of stock options, shares Exercised Liabilities and Equity [Abstract] Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit) Shelf Registration Statement [Member] Shelf Registration Statement [Member] Shelf Registration Statement [Member] Present value of operating lease liability Present value of operating lease liability Present value of operating lease liability Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Acquired In Process Research And Development Expense [Member] Acquired In Process Research And Development Expense [Member] Acquired In Process Research And Development Expense [Member] Increase (Decrease) in Accounts Payable, Total Increase (Decrease) in Accounts Payable Accounts payable Credit Facility [Domain] Other Deferred Compensation Arrangements, Liability, Current and Noncurrent Other non-current liability Other non-current liability Equity [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Issued Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Weighted-Average Exercise Price, Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Equity Components [Axis] Equity Components First Product. First Product [Member] First Product [Member] Option Exercise Fee Option Exercise Fee Option Exercise Fee Related Party Transaction Expenses From Transaction With Related Party Related Party Transaction Expenses From Transaction With Related Party Related Party Transaction Expenses From Transaction With Related Party November 15, 2030 [Member] Fifteen November Two Thousand Thirty [Member] Fifteen November Two Thousand Thirty [Member] Local Phone Number Local Phone Number Sale of Stock [Axis] Sale of Stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted-Average Exercise Price,Options exercisable at June 30, 2023 November 15, 2029 [Member] Fifteen November Two Thousand Twenty Nine [Member] Fifteen November Two Thousand Twenty Nine [Member] Present value adjustment Present value adjustment Present value adjustment Defined Contribution Plan [Table] Defined Contribution Plan [Table] Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of preferred stock Statement of Cash Flows [Abstract] Repurchase of unvested restricted common stock, shares Stock Repurchased and Retired During Period, Shares Repurchase of unvested restricted common stock Advance Potential Milestone Payment Advance payment Advance potential milestone payment Organization, Consolidation and Presentation of Financial Statements [Abstract] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax 2024 Purchase Obligation, to be Paid, Year One Issuance of common stock price per share Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Accrued Professional Fees Accrued professional and consultant fees Due To Related Parties Due To Related Parties Due To Related Parties Cumulative Effect, Period of Adoption [Axis] Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized stock based compensation expense, Weighted average recognition period Partially achieved shares on performance received Partially Achieved Shares On Performance Received Partially achieved shares on performance received Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Vested and Expected to vest at June 30, 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of shares of common stock authorized for issuance Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] License and Collaboration Agreements Collaborative Arrangement Disclosure [Text Block] Maximum [Member] Maximum [Member] Emerging Growth Company Emerging Growth Company Policy [Text Block] Emerging Growth Company Retirement Plan Name [Axis] Retirement Plan Name Convertible preferred stock, shares outstanding Temporary Equity, Shares Outstanding Related Party Transaction [Axis] Related Party Transaction IPR&D expense. In Process Research And Development Expense [Member] IPR&D Expense [Member] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Nature of the Business and Basis of Presentation Fair Value, Inputs, Level 3 [Member] Level 3 [Member] APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Warrant expense Fair Value Adjustment of Warrants Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Completion Fee. Completion Fee Completion fee General and Administrative Expense [Member] Selling, General and Administrative [Member] Supplemental disclosure of cash flow information Noncash Investing and Financing Items [Abstract] Research and development expenses Research And Developments In Process Research And Developments In Process Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Forfeited Accrued expenses Accrued Liabilities Accounts payable and accrued expenses Payments of initial public offering costs Payments of Initial Public Offering Costs Payments of Initial Public Offering Costs Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] City Area Code City Area Code Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Marketable Securities Operating Leases, Future Minimum Payments Due, Total Operating Leases, Future Minimum Payments Due Future minimum payments under non-cancelable purchase obligations Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Intrinsic value of options Unrealized loss on marketable securities. Unrealized Loss on Marketable Securities Unrealized Losses Defined Contribution Plan [Text Block] Defined Contribution Plan Convertible preferred stock, liquidation preference Temporary Equity, Liquidation Preference Weighted-average common shares outstanding, basic and diluted Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares outstanding, basic and diluted Other Commitments [Line Items] Four Hundred One K Plan Member Four Hundred One K Plan [Member] 401(k) Plan Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Percentage of commision paid, Gross proceeds from future sales Percentage of Commision Paid, Gross Proceeds From Future Sales Percentage of Commision Paid, Gross Proceeds From Future Sales Statement [Table] Statement [Table] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Activity Schedule of Related Party Transactions, by Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Weighted Average Fair Values and Valuation Assumptions Document Fiscal Period Focus Document Fiscal Period Focus Lessee, Operating Lease, Liability, to be Paid Total lease payments Related Party Transactions Disclosure [Text Block] Related Party Transactions 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Statement [Line Items] Statement [Line Items] Amount Paid As Pre Paid Funding For Research Plan Amount Paid As Pre Paid Funding For Research Plan Amount Paid As Pre Paid Funding For Research Plan Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities excluded from computation of earnings per share, amount Other Accrued Liabilities Other Lease, Cost Total lease cost Royalty Expense Royalty expense Asset Class [Domain] Asset Class Cumulative Effect, Period of Adoption [Domain] Common Stock [Member] Common Stock [Member] Revenue From Related Party Revenue From Related Party Other Commitments [Table] Common Stock, Shares Held in Employee Trust, Shares Common stock shares held Mithril Group [Member] Mithril Group [Member] Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Stock Repurchased During Period, Value Shares repurchased, Fair value Issuance of Series A convertible preferred stock in exchange for license and common stock Issuance of Series A convertible preferred stock in exchange for license and common stock Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Summary of Share Based Compensation Expense Recognized Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value, Exercisable at June 30, 2023 Accretion (Amortization) of Discounts and Premiums, Investments Net amortization of premiums and accretion of discounts on marketable securities Net amortization of premiums and accretion of discounts on marketable securities Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Antidilutive Securities, Name [Domain] Entity Bankruptcy Proceedings, Reporting Current Entity Bankruptcy Proceedings, Reporting Current Treasury Stock, Value Treasury stock Treasury stock Treasury Stock, Value, Total Treasury stock, at cost; 0 shares and 468,751 shares at September 30, 2022 and December 31, 2021, respectively Cover [Abstract] Selling, General and Administrative Expense, Total Selling, General and Administrative Expense Selling, general and administrative Document Fiscal Year Focus Document Fiscal Year Focus Sale of Stock [Domain] Sale of Stock The scripps research institute member. The Scripps Research Institute [Member] TSRI Security Exchange Name Security Exchange Name Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Share-based payment award, expiration period Lessee, operating lease total lease space. Lessee, Operating Lease, Total Lease Space Lease space Annual Fee Annual Fee Annual fee Recently Issued and Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Preferred Stock, Shares Issued, Total Preferred Stock, Shares Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Authorized Preferred stock, shares authorized (in shares) Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Operating lease right-of-use asset recognized upon adoption of ASC 842 Weighted-Average Exercise Price,Forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Accrued Employee Benefits, Current Accrued employee compensation Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized Recognized expense Accrued external research development and manufacturing expenses. Accrued External Research Development And Manufacturing Expenses Current Accrued external research, development and manufacturing costs Stock Issued During Period, Value, Stock Options Exercised Vesting of restricted common stock from early-exercised options Exercise of stock options Entity Emerging Growth Company Entity Emerging Growth Company Exercise Fee. Exercise Fee Exercise fee Organization, Consolidation and Presentation of Financial Statements. Organization Consolidation And Presentation Of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table] Intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Convertible Preferred Stock, Shares Issued upon Conversion Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock Convertible preferred Stock Shares Issued Upon Conversion Other income Other Nonoperating Gains (Losses) Amendment Flag Amendment Flag Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Expenses Annual gross revenue Annual gross revenue Annual gross revenue IPO [Member] IPO [Member] Prepaid external research development and manufacturing expenses. Prepaid External Research Development And Manufacturing Expense Current Prepaid external research, development and manufacturing costs Securities Act File Number Entity File Number Adimab Assignment Agreement. Adimab Assignment Agreement [Member] Adimab Assignment Agreement [Member] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Schedule of impact of the adoption [table text block] Summary of impact of the adoption [table text block] Summary of the impact of the adoption Share-Based Payment Arrangement [Abstract] Accounts Payable, Current, Total Accounts Payable, Current Accounts payable Costs and Expenses, Total Costs and Expenses Expenses Operating Expenses Total operating expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Entity Address, Address Line Two Entity Address, Address Line Two Preferred stock (undesignated), $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding at September 30, 2023 and December 31, 2022 Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Carrying Value Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Schedule of Nonvested Share Activity [Table Text Block] Schedule of Unvested Common Stock Options Title of Individual [Axis] Number of shares issued Sale of Stock, Number of Shares Issued in Transaction Investment Type [Axis] Investment Type Warrant exercise price Weighted average exercise price of Warrant Per Share Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Warrant or Right [Domain] 2025 Purchase Obligation, to be Paid, Year Two Earnings Per Share [Text Block] Net Loss Per Share Entity Address, Address Line One Entity Address, Address Line One Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Antidilutive Securities [Axis] Other current liabilities Other Liabilities, Current Tabular disclosure of the carrying amounts of prepaid expenses and other current assets. Schedule Of Prepaid Expenses And Other Current Assets Table [Text Block] Summary of Prepaid Expenses and Other Current Assets Research and Development Arrangement [Member] Subsequent Event Type [Domain] Subsequent Event Type Schedule of Stock by Class [Table Text Block] Schedule of Preferred Stock Income Statement Location [Axis] Income Statement Location Variable Lease, Cost Variable lease cost Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Prepaid Insurance Prepaid insurance Fixed asset purchases in account payable and accrued expenses Fixed asset purchases in account payable and accrued expenses Purchases of property and equipment in accounts payable and accrued expenses Series C Preferred Stock [Member] Series C Preferred Stock [Member] Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Share Price Repurchased common stock, per share Sale Leaseback Transaction, Monthly Rental Payments Monthly rental payments Royalty Based on Net Sales of Licensed Products, Percentage. Royalty Based On Net Sales Of Licensed Products Percentage Royalty Based on Net Sales of Licensed Products, Percentage Product and Service [Axis] Product and Service Federal Agency Securities [Member] Federal agency securities [Member] Federal agency securities [Member] Unaudited Interim Financial Information Unaudited Interim Financial Information Policy [Text Block] Unaudited Interim Financial Information share based compensation arrangement by share based payment award percentage of voting interests threshold. Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Voting Interests Threshold Combined voting power on all classes of stock threshold Title of 12(b) Security Title of 12(b) Security Investments [Domain] Investments Fair Value Assets, Fair Value Adjustment Fair Value Available for sale marketable securities Available for sale marketable securities Available for sale marketable securities Treasury Stock [Member] Treasury Stock, Common [Member] Cantor Fitzgerald & Co [Member] Cantor Fitzgerald & Co [Member] Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Exercised Total lease payments Purchase Obligation Purchase Obligation Proceeds from issuance of common stock, net of commissions and underwriting discounts Proceeds from issuance of common stock, net of commissions and underwriting discounts Proceeds from issuance of common stock, net of commissions and underwriting discounts Cash fee payment per month Cash fee payment per month Cash and Cash Equivalents [Axis] Operating lease liability adjustment. Operating Lease Liability Adjustment Present value adjustment Present value adjustment Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Exercisable at June 30, 2023 Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding Common stock, shares outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-Based Payment Arrangement [Text Block] Share Based Compensation Non-cash payments Non cash payments Non cash payments VYD222 Drug Substance VYD Two Hundred Twenty Two DrugSubstance [Member] VYD Two Hundred Twenty Two DrugSubstance [Member] Aggregate fee Other Commitment Other Commitment, Total Drug Delivery Fee Drug Delivery Fee Drug Delivery Fee Income Statement Location [Domain] Income Statement Location Weighted-Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price PHP Warrant [Member] PHP Warrant [Member] Document Type Document Type Net cash provided by (used in) investing activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Document Quarterly Report Document Quarterly Report Marketable Securities, Total Marketable Securities Marketable securities Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income (loss) Long-Term Purchase Commitment [Line Items] Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Entity Filer Category Entity Filer Category Other non-current assets Increase (Decrease) in Other Noncurrent Assets Other non-current assets Increase (Decrease) in Accrued Liabilities, Total Increase (Decrease) in Accrued Liabilities Accrued expenses A D G20 Drug Substance A D G20 Drug Substance [Member] ADG20 Drug Substance [Member] Delivery Fee. Delivery Fee Delivery fee Payments to Acquire Marketable Securities Purchase of marketable securities Purchase of marketable securities Asset Class [Axis] Asset Class Total other income Nonoperating Income (Expense) Liabilities Total liabilities Equity, Attributable to Parent Balances Balances Total stockholders' equity Accrued Liabilities [Abstract] Net Income (Loss) Net loss Net loss Net loss attributable to common stockholder Nonoperating Income (Expense) [Abstract] Other income (expense): Cash and Cash Equivalents [Domain] Preferred Stock [Text Block] Convertible Preferred Stock Statement of Financial Position [Abstract] Weighted-average common shares outstanding, basic and diluted Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total 2026 Purchase Obligation, to be Paid, Year Three Credit Facility [Axis] Amortization of operating lease right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term Use of Estimates, Policy [Policy Text Block] Use of Estimates Income Tax Disclosure [Text Block] Income Taxes Preferred Stock, Fair Value. Preferred Stock Fair Value Shares issued, Fair value Weighted-Average Exercise Price, Beginning Balance at December 31, 2022 (Per Share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-Average Exercise Price, Ending Balance at June 30, 2023 (Per Share) PHP Population Health Partners [Member] Population Health Partners [Member] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted Percentage Of Total Number Of Shares Of Common Stock Outstanding Percentage Of Total Number Of Shares Of Common Stock Outstanding Percentage of number of shares of common stock outstanding Antidilutive Securities Excluded From Computation Of Earnings Per Share LineItems Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Fair Value Disclosures [Abstract] Two Thousands Twenty One Equity Incentive Plan [Member] Two Thousands Twenty One Equity Incentive Plan [Member] 2021 Equity Incentive Plan Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Measurement Frequency [Domain] Measurement Frequency Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Vested Stock Issued During Period, Shares, New Issues Issuance of common stock, shares Class of Warrant or Right [Axis] Proceeds from Sale and Maturity of Marketable Securities, Total Proceeds from Sale and Maturity of Marketable Securities Maturities of marketable securities Income Tax Disclosure [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class Marketable Securities [Table Text Block] Summary of Marketable Securities